Examkin

Patient Management

2074 soru

Tüm türler2,074Çoktan seçmeli1,048Çoklu seçim393Eşleştirme221Sıralama412
Soru 1101Soru →

An ambulatory appointment is scheduled for a 41-year-old male delivery driver to evaluate his blood pressure management. He was diagnosed with primary hypertension six months ago and was prescribed daily amlodipine. He also has a history of moderate persistent asthma, which is well controlled on a daily inhaled corticosteroid-formoterol inhaler.

During today's visit, his blood pressure is 158/98 mmHg and his heart rate is 76/min. When asked about his medication usage, the patient states, "I only take the blood pressure pill when my neck gets stiff or I feel a headache coming on. Otherwise, I feel completely normal, so I try to avoid putting unnecessary chemicals into my body."

Which of the following is the most appropriate initial response by the physician?

Cevabı ve açıklamayı göster

Cevap: Can you explain to me your understanding of what high blood pressure does to your body when you do not have symptoms?

Cevap

The most appropriate initial response is to ask the patient to explain their understanding of how high blood pressure affects the body in the absence of symptoms.
The correct response utilizes an open-ended question to explore the patient's underlying health beliefs. This patient exhibits a common misconception that hypertension is a symptomatic disease requiring treatment only during 'flare-ups' (e.g., headaches). Assessing the patient's illness perception is the fundamental first step in patient counseling. It allows the physician to understand the root cause of the non-adherence and creates a non-judgmental opening to provide targeted health education—specifically, explaining that hypertension often causes silent, progressive end-organ damage even when a person feels completely normal.

Adım Adım Çözüm

1
Identify the primary barrier to medication adherence presented in the vignette.
The patient believes that hypertension medications are only necessary when acute symptoms (like neck stiffness or headaches) are present.
Recognizing the specific health misconception is required before formulating an educational or counseling intervention.
2
Select the communication strategy that best addresses the identified barrier.
Use an open-ended question to explore the patient's illness representation and health literacy.
Directly challenging the patient, using fear tactics, or assuming alternative causes (like side effects) can damage the therapeutic alliance. Exploring their understanding allows the physician to gently introduce corrective health education about hypertension being a 'silent' disease.
3
Evaluate the remaining options for clinical and ethical appropriateness.
Eliminate options that prescribe contraindicated medications (nonselective beta-blockers in asthma), misapply screening guidelines (colonoscopy at age 41), or defensively terminate counseling.
Physician counseling must maintain clinical safety and adhere to evidence-based guidelines while fostering patient autonomy.

Anahtar Kavram

When patients exhibit non-adherence due to a misunderstanding of their disease process (e.g., treating asymptomatic hypertension as a symptom-driven illness), the physician should first use open-ended inquiry to explore the patient's health beliefs before providing corrective education.
Soru 1102Soru →

A 75-year-old woman is evaluated in the emergency department for sudden-onset right-sided pleuritic chest pain and mild shortness of breath that began 6 hours ago. She has a history of essential hypertension and osteoarthritis. Current medications include lisinopril and acetaminophen. Vital signs are temperature 37.1°C (98.8°F), blood pressure 138/86 mm Hg, pulse 104/min, and respirations 18/min. Oxygen saturation is 96% on room air. Physical examination is unremarkable except for mild, chronic right lower extremity edema. The patient is alert, comfortable, and conversing in full sentences. Laboratory evaluation shows a serum creatinine of 1.0 mg/dL. High-sensitivity troponin I is undetectable, and N-terminal pro-B-type natriuretic peptide (NT-proBNP) is 85 pg/mL (normal: <125 pg/mL). CT pulmonary angiography reveals a segmental pulmonary embolism in the right lower lobe. Transthoracic echocardiography demonstrates normal right ventricular size and systolic function without evidence of right heart strain. The patient is administered a dose of oral apixaban. Her pain is completely relieved with oral analgesics. She lives with her healthy, supportive daughter 15 minutes away from the hospital and is ambulatory at baseline. Which of the following is the most appropriate disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Discharge home with oral anticoagulation and prompt outpatient follow-up

Cevap

The most appropriate disposition is to discharge the patient home with oral anticoagulation and prompt outpatient follow-up.
The correct disposition is discharging the patient home with oral anticoagulation and prompt outpatient follow-up. The standard of care for acute pulmonary embolism has evolved significantly to favor outpatient management for carefully selected individuals. Patients who are hemodynamically stable, have a low-risk clinical score (such as a simplified Pulmonary Embolism Severity Index [sPESI] of 0), possess normal right ventricular function on imaging, and exhibit negative cardiac biomarkers are definitively classified as low risk. When these objective medical criteria are met alongside adequate social support, well-controlled pain, and no contraindications to direct oral anticoagulants, the patient should be discharged directly from the emergency department.

Adım Adım Çözüm

1
Evaluate the patient's hemodynamic status.
The patient is hemodynamically stable with a blood pressure of 138/86 mm Hg.
Hemodynamic instability would classify the event as a massive (high-risk) pulmonary embolism, necessitating intensive care and reperfusion therapy.
2
Assess clinical risk using a validated stratification tool such as the simplified Pulmonary Embolism Severity Index (sPESI).
The patient has an sPESI score of 0 (age < 80, no cancer, no chronic cardiopulmonary disease, heart rate < 110/min, systolic BP >= 100 mm Hg, O2 sat >= 90%).
An sPESI score of 0 identifies the patient as being at very low clinical risk for short-term mortality.
3
Review cardiac biomarkers and right ventricular imaging.
Troponin and NT-proBNP are normal, and there is no evidence of right ventricular strain on echocardiography.
The absence of right ventricular dysfunction and myocardial necrosis rules out an intermediate-risk (submassive) pulmonary embolism, confirming the patient remains in the low-risk category.
4
Assess social and functional factors to determine the final care setting.
The patient is ambulatory, her pain is well-controlled with oral analgesics, and she has strong home support from her daughter.
Low-risk patients with adequate social support and no bleeding contraindications should be discharged home to avoid the unnecessary risks and costs associated with hospitalization.

Anahtar Kavram

Risk stratification of acute pulmonary embolism using clinical scores, biomarkers, and echocardiography to identify low-risk patients eligible for safe outpatient management.
Soru 1103Soru →

During a routine outpatient visit, a physician sees a 62-year-old female with a known history of severe chronic obstructive pulmonary disease (COPD) and a 40-pack-year smoking history. Upon entering the examination room, the physician notes a strong odor of tobacco smoke on the patient's clothing. When the physician gently asks about her current tobacco use, the patient crosses her arms, raises her voice, and states, "My grandfather smoked a pack a day until he died peacefully at 90! Besides, you already told me my lungs are permanently damaged, so putting myself through the misery of quitting now won't fix anything." Which of the following is the most appropriate initial response by the physician?

Cevabı ve açıklamayı göster

Cevap: It sounds like you believe that going through the difficult process of quitting would not offer you any meaningful health benefits at this point.

Cevap

The statement reflecting the patient's belief that quitting would not offer meaningful health benefits.
The patient is in the precontemplation stage of change, characterized by resistance and a lack of intent to modify her behavior. According to the principles of motivational interviewing, the most effective initial step when encountering resistance is to utilize reflective listening. By stating, 'It sounds like you believe...', the physician acknowledges and validates the patient's perspective without agreeing or judging. This approach de-escalates defensiveness, builds therapeutic rapport, and allows the physician to eventually ask permission to provide education (the 'Ask-Tell-Ask' framework). Confrontational tactics, ultimatums, or unsolicited medical facts are counterproductive at this stage.

Adım Adım Çözüm

1
Assess the patient's readiness to change.
The patient is defensive, minimizes the risks (citing her grandfather), and denies the benefits of quitting, indicating she is in the precontemplation stage.
Identifying the stage of change dictates the appropriate counseling framework.
2
Select the appropriate communication strategy for the precontemplation stage.
Avoid argumentation, scare tactics, or immediate advice-giving. Instead, use motivational interviewing techniques such as reflective listening.
Confronting a defensive patient directly increases resistance, whereas validating their current emotional state builds rapport and opens the door for future interventions.
3
Evaluate the distractors for factual and ethical accuracy.
The other options contain medical, ethical, or pharmacokinetic inaccuracies and utilize coercive or confrontational language.
In standardized assessments, distractors in communication questions often combine poor interpersonal tone with specific clinical misconceptions.

Anahtar Kavram

Motivational interviewing techniques (reflective listening) for patients in the precontemplation stage of behavioral change.
Soru 1104Soru →

A 64-year-old man with end-stage liver disease due to alcohol use disorder is brought to the emergency department by his daughter after vomiting large amounts of blood at home. On presentation, his blood pressure is 80/50 mm Hg, and his heart rate is 125/min. Physical examination reveals jaundice, marked ascites, and asterixis. He is lethargic and oriented only to his name. An advance directive in his electronic medical record explicitly names his daughter as his healthcare surrogate and states he does not want mechanical ventilation under any circumstances. The medical team determines he requires immediate endotracheal intubation for airway protection prior to urgent upper endoscopy. The physician explains the situation to the daughter, who refuses consent for intubation, stating, "He made it very clear he never wanted to be on a breathing machine, even if it meant he would die." When the physician briefly rouses the patient and asks what he wants, he mumbles, "Help me, don't let me die," before falling back asleep. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Honor the daughter's refusal and provide non-invasive medical management

Cevap

Honor the daughter's refusal and provide non-invasive medical management
The correct course of action is to honor the daughter's refusal and provide non-invasive medical management. This patient currently lacks clinical decision-making capacity due to hepatic encephalopathy, as demonstrated by his disorientation, lethargy, and asterixis. When a patient lacks capacity, medical decisions fall to their legally appointed healthcare surrogate. The surrogate is expected to exercise substituted judgment—making the decision the patient would have made if they possessed capacity. Because the advance directive explicitly names the daughter and outlines a refusal of mechanical ventilation, her decision must be respected. The patient's momentary plea does not override the directive because he lacks the capacity to fully comprehend his medical situation and change his goals of care.

Adım Adım Çözüm

1
Assess the patient's clinical decision-making capacity.
The patient has asterixis, lethargy, and disorientation, indicating hepatic encephalopathy. He lacks clinical capacity.
Capacity is required for a patient to make or change medical decisions. Without it, a surrogate must step in.
2
Identify the appropriate decision-maker.
The advance directive explicitly names the daughter as the healthcare surrogate.
Legally designated surrogates in an advance directive take precedence over default next-of-kin hierarchies.
3
Determine the surrogate's decision and its ethical basis.
The daughter refuses intubation based on the patient's previously stated wishes.
Surrogates must use substituted judgment, making the decision the patient would have made if they had capacity.
4
Implement the management plan.
Respect the surrogate's decision to refuse intubation and proceed with non-invasive care.
Honoring patient autonomy through their chosen surrogate is the ethical and legal standard.

Anahtar Kavram

In patients lacking clinical capacity, medical decisions must be guided by their designated healthcare surrogate using substituted judgment based on the patient's advance directives, even if the incapacitated patient expresses momentary conflicting desires.
Soru 1105Soru →

A 54-year-old man presents to the clinic for a follow-up evaluation. One month ago, his blood pressure was 152/96 mm Hg, and today it is 154/98 mm Hg. His medical history is significant for osteoarthritis and a recently diagnosed active gastric ulcer. At the previous visit, the physician recommended initiating amlodipine. Today, the patient admits he never filled the prescription. He states, "I read on an internet forum that blood pressure pills destroy your kidneys. I refuse to take them. Instead, I am going to strictly limit my salt intake and start taking high-dose ibuprofen every day for my joint pain so I can start jogging." He insists on proceeding with this alternative plan.

Which of the following statements by the physician represents the most appropriate initial counseling approach?

Cevabı ve açıklamayı göster

Cevap: Limiting your salt intake and preparing to exercise are excellent goals. Can you tell me more about what you read regarding blood pressure medications and kidney damage?

Cevap

The most appropriate response is to validate the patient's positive lifestyle intentions while using an open-ended question to explore his specific fears about kidney damage.
The correct response utilizes core principles of motivational interviewing and patient-centered communication. When a patient presents with medical misinformation and resistance to therapy, directly confronting them or lecturing them often entrenches their resistance. The most effective initial step is to validate the positive aspects of their plan (e.g., limiting salt intake and preparing to exercise) to build a therapeutic alliance. Following this, the physician should use an open-ended question to explore the patient's specific health beliefs and fears. Understanding exactly what the patient read about kidney damage provides the physician with the context needed to gently and effectively correct the misconception in subsequent dialogue.

Adım Adım Çözüm

1
Identify the primary barrier to medication adherence.
The patient is refusing amlodipine due to a specific misconception (fear of kidney destruction) derived from an internet forum.
Understanding the root cause of non-adherence dictates the counseling strategy.
2
Evaluate the patient's proposed alternative plan for clinical safety.
The patient plans to start a low-salt diet, exercise, and take high-dose ibuprofen. While diet and exercise are positive, high-dose NSAIDs are absolutely contraindicated given his active gastric ulcer and uncontrolled hypertension.
The physician must address both the non-adherence and the dangerous self-medication plan.
3
Select the optimal initial communication strategy.
The physician should first validate the patient's positive efforts (salt restriction, desire to exercise) to build a therapeutic alliance, and then use an open-ended question to explore the misinformation regarding kidney damage.
Directly arguing with the patient or lecturing them often increases resistance. Exploring their beliefs first allows the physician to provide targeted, respectful education subsequently.

Anahtar Kavram

Patient-Centered Communication and Motivational Interviewing
Soru 1106Soru →

A physician is evaluating four different patients in an outpatient clinic. Each patient expresses a specific barrier to adhering to their recommended medical management. Match each patient statement to the most appropriate initial physician counseling strategy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Patient with asthma: 'I only use my daily steroid inhaler when my chest feels tight, which is usually right before I go for a run.'
Patient with diabetes: 'My mother went blind from diabetes, so I know it is just a matter of time before I lose my vision too, regardless of my diet.'
Patient with hypertension: 'I stopped taking my hydrochlorothiazide because it makes me have to use the restroom repeatedly during my long commute to work.'
Patient who smokes: 'I understand smoking is bad for my heart, but it is the only way I can calm down after dealing with difficult customers all day.'

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The asthma patient requires clarification on controller versus rescue therapies; the diabetic patient requires addressing fatalistic beliefs; the hypertensive patient requires medication timing adjustment; and the smoking patient requires exploring alternative stress reduction techniques.
Effective patient counseling requires matching the physician's intervention to the specific barrier identified. A knowledge deficit (asthma) requires targeted education; fatalism (diabetes) requires cognitive reframing and emphasizing agency; an unacceptable side effect (hypertension) requires practical medical adjustment; and emotional reliance (smoking) requires validating the emotion while collaborating on substituting the behavior.

Adım Adım Çözüm

1
Analyze the asthma patient's statement.
Identified a knowledge gap regarding medication purpose.
Using a daily steroid only for acute symptoms indicates a misunderstanding of maintenance versus rescue therapy.
2
Analyze the diabetic patient's statement.
Identified fatalism and lack of perceived control.
The belief that complications are inevitable regardless of behavior requires cognitive reframing to improve self-efficacy.
3
Analyze the hypertensive patient's statement.
Identified a lifestyle-limiting medication side effect.
Diuretic-induced polyuria during a commute is a practical barrier that can often be resolved by altering the dosing schedule.
4
Analyze the smoking patient's statement.
Identified smoking as a primary coping mechanism for stress.
Before behavior change can occur, the physician must validate the psychological function of the habit and help substitute it.

Anahtar Kavram

Identifying and targeting the specific patient barrier (knowledge deficit, psychological reliance, or practical obstacle) is essential for effective health education and improving adherence.
Tahmini Süre:1m 30s
Soru 1107Soru →

Match each of the following ambulatory patients with the single most appropriate screening recommendation according to current United States Preventive Services Task Force (USPSTF) guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 70-year-old biological male presenting to the ambulatory clinic. He smoked 3 cigarettes daily from age 18 to 24 but has not smoked since. His last colonoscopy was 5 years ago, and he had a normal lipid panel last month.
A 42-year-old biological female presenting for a wellness visit. She has never smoked, has a BMI of 31 kg/m^2, and had a normal Pap smear 2 years ago. She has no known medical conditions.
A 58-year-old biological female in the clinic for follow-up. She smoked 1.5 packs of cigarettes daily for 20 years and quit 12 years ago. She had a normal mammogram and normal colonoscopy 2 years ago.
A 23-year-old biological female presenting for contraceptive counseling. She is a lifelong nonsmoker, sexually active with a new male partner, and had a normal physical exam today. She has never been tested for sexually transmitted infections.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings match the 70-year-old male with an abdominal ultrasound, the 42-year-old female with diabetes screening, the 58-year-old female with low-dose CT, and the 23-year-old female with chlamydia/gonorrhea testing.
Each patient profile directly aligns with specific USPSTF grade A or B recommendations based on their age, sex, BMI, and exposure history. The 70-year-old male needs an abdominal ultrasound for AAA screening due to his age and lifetime smoking history of >100 cigarettes. The 42-year-old female requires diabetes screening due to her age and elevated BMI. The 58-year-old female requires a low-dose CT scan because she meets the 20 pack-year threshold and quit within the last 15 years. The 23-year-old female needs STI screening because she is sexually active and under the age of 25.

Adım Adım Çözüm

1
Evaluate the 70-year-old male's risk factors based on age and exposure.
Identify that a male aged 65-75 with a history of smoking >100 cigarettes needs one-time AAA screening.
USPSTF guidelines mandate a one-time abdominal ultrasound for this exact demographic to prevent catastrophic aneurysm rupture.
2
Evaluate the 42-year-old female's risk factors based on age and biometrics.
Identify that her age (35-70) and BMI (>25 kg/m^2) meet criteria for diabetes screening.
USPSTF recommends HbA1c or fasting glucose for overweight adults in this age range to catch prediabetes early.
3
Evaluate the 58-year-old female's smoking history.
Calculate her smoking history as 30 pack-years (1.5 packs x 20 years) and note she quit 12 years ago.
She meets criteria for annual low-dose CT lung cancer screening because she is 50-80 years old, has a >20 pack-year history, and quit <15 years ago.
4
Evaluate the 23-year-old female's demographics.
Note she is under 25 and sexually active.
USPSTF recommends annual chlamydia and gonorrhea screening for all sexually active women 24 years or younger.

Anahtar Kavram

Current USPSTF guidelines for age- and risk-appropriate preventive screening.
Tahmini Süre:2m 0s
Soru 1108Soru →

A 71-year-old man with metastatic pancreatic adenocarcinoma and an irreversible malignant bowel obstruction is receiving acute inpatient care. Following extensive multidisciplinary discussions, the patient and his surrogate decision-maker have decided to prioritize quality of life and wish to pursue comfort measures at home. Arrange the following steps in the correct chronological sequence to appropriately execute this patient's disposition and transition to home hospice care.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for transitioning a patient to home hospice is: 1) Establish terminal prognosis and goals, 2) Obtain formal hospice benefit election, 3) Modify inpatient orders to focus on comfort, 4) Coordinate delivery of home equipment and medications, and 5) Transfer primary care oversight to the hospice agency.
Transitioning a patient to home hospice requires a step-wise approach to ensure legal compliance, patient comfort, and a safe home environment. Clinical prognostication and goal-setting must occur first to medically justify hospice eligibility. This is immediately followed by obtaining legal consent (hospice election). Once consent is obtained, the acute care team modifies current inpatient orders to stop distressing, non-palliative care while the patient remains in the hospital. Concurrently, the destination (home) must be prepared with necessary equipment and comfort medications before the patient can physically leave. Finally, the physical transfer occurs alongside the formal handoff of clinical responsibility.

Adım Adım Çözüm

1
Determine eligibility and goals
Prognosis documented and goals aligned
Hospice care requires a physician-certified life expectancy of 6 months or less if the disease runs its normal course.
2
Secure legal and administrative consent
Hospice benefit formally elected
The patient or surrogate must officially waive traditional insurance coverage for curative treatments related to the terminal illness.
3
Implement palliation in the acute setting
Discontinuation of invasive or routine diagnostics
Immediate modification of inpatient orders prevents unnecessary suffering (e.g., morning blood draws) while the physical discharge is being arranged.
4
Prepare the receiving environment
Equipment and medications secured at the residence
A safe transition requires that symptom management tools (e.g., oxygen, opioids) are physically present at home before the patient arrives.
5
Execute transfer and clinical handoff
Patient transferred to home hospice oversight
Primary case management officially shifts from the acute care hospitalist to the hospice medical director and interdisciplinary team.

Anahtar Kavram

Chronological workflow for safe transitions from acute inpatient care to home hospice.
Soru 1109Soru →

Match each clinical presentation of nausea and vomiting in the palliative care setting with the most appropriate targeted initial pharmacologic intervention based on its underlying pathophysiologic mechanism.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A patient with advanced malignancy presenting with nausea, early satiety, and upper abdominal bloating, without evidence of mechanical bowel obstruction.
A patient with widely metastatic lung cancer who develops early morning projectile vomiting and a progressive global headache.
A patient receiving palliative chemotherapy who experiences acute, severe emesis beginning 6 hours after an infusion of highly emetogenic agents.
A patient with terminal illness whose nausea and emesis are strictly exacerbated by head turning and transitioning from a supine to a seated position.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct mapping aligns each presentation of nausea with its pathophysiologic mechanism: gastroparesis requires metoclopramide, increased intracranial pressure requires dexamethasone, acute chemotherapy-induced nausea requires ondansetron, and vestibular nausea requires scopolamine.
Each match represents the standard of care for targeted antiemetic therapy in palliative medicine. Early satiety and bloating suggest gastroparesis, best treated with the prokinetic metoclopramide. Morning vomiting with headache suggests increased intracranial pressure, treated with dexamethasone to reduce edema. Acute nausea after chemotherapy is mediated by serotonin, treated with ondansetron. Movement-triggered nausea is vestibular, treated with scopolamine.

Adım Adım Çözüm

1
Identify the primary underlying mechanism of nausea for each patient presentation based on key clinical clues.
Mechanisms identified: autonomic gastroparesis (early satiety), increased intracranial pressure (morning vomiting/headache), serotonin-mediated toxicity (post-chemotherapy), and vestibular stimulation (positional triggers).
Nausea in palliative care is multifactorial; determining the dominant pathway is essential for selecting effective, targeted therapy rather than relying on broad-spectrum agents.
2
Match the identified mechanism to the corresponding receptor-specific drug class and pharmacological agent.
Gastroparesis pairs with prokinetics (metoclopramide); increased intracranial pressure pairs with corticosteroids (dexamethasone); acute chemotherapy-induced nausea pairs with 5-HT3 antagonists (ondansetron); and vestibular nausea pairs with anticholinergics (scopolamine).
Targeting the specific neuroreceptor pathway (D2, 5-HT3, ACh, or direct pressure reduction) maximizes symptomatic relief while minimizing unnecessary side effects.

Anahtar Kavram

In palliative care, the treatment of nausea and vomiting must be mechanism-based, utilizing targeted pharmacologic agents that antagonize the specific pathways (e.g., dopamine, serotonin, histamine, acetylcholine) mediating the patient's symptoms.
Soru 1110Soru →

A 35-year-old man comes to the clinic for a routine health maintenance visit. He has a history of bipolar I disorder, which has been well-controlled on lithium monotherapy for the past 5 years. He reports no recent manic or depressive episodes and states that his mood has been highly stable. He denies polyuria, polydipsia, fatigue, or unintentional weight changes. He takes no other medications and has no other known medical conditions. Vital signs are within normal limits, and the physical examination is unremarkable. A recent serum lithium level was 0.8 mEq/L0.8 \text{ mEq/L} (therapeutic range: 0.6−1.2 mEq/L0.6-1.2 \text{ mEq/L}). Which of the following laboratory studies are indicated for routine ongoing monitoring of this patient's long-term pharmacotherapy? (Select three)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Serum creatinine; Thyroid-stimulating hormone; Serum calcium

Cevap

The correct parameters for ongoing lithium monitoring are serum creatinine, thyroid-stimulating hormone, and serum calcium.
Lithium has a narrow therapeutic index and several well-established, long-term adverse effects affecting specific organ systems. It is primarily excreted unchanged by the kidneys and can cause chronic tubulointerstitial nephropathy or nephrogenic diabetes insipidus, necessitating periodic monitoring of renal function via serum creatinine. Lithium also frequently causes thyroid dysfunction (most commonly hypothyroidism) by interfering with the synthesis and release of thyroid hormones, requiring regular assessment of thyroid-stimulating hormone (TSH). Additionally, lithium can alter calcium metabolism and lead to hypercalcemia via medication-induced hyperparathyroidism; thus, serum calcium levels should also be periodically evaluated. In clinically stable patients on maintenance therapy, these parameters are typically checked every 6 to 12 months.

Adım Adım Çözüm

1
Identify the patient's current medication and its known long-term adverse effects.
The patient is on long-term lithium therapy. Chronic lithium use is known to be toxic to the kidneys, the thyroid gland, and the parathyroid glands.
Recognizing the organ-specific toxicity profile of a drug is essential for selecting appropriate, guideline-concordant surveillance tests.
2
Select the specific laboratory tests that screen for these drug-induced organ toxicities.
Serum creatinine evaluates for lithium-induced nephropathy, thyroid-stimulating hormone screens for hypothyroidism, and serum calcium screens for hyperparathyroidism.
Standard psychiatric guidelines mandate periodic monitoring of these exact parameters to detect asymptomatic complications early.
3
Differentiate lithium's monitoring requirements from those of other psychotropic medications.
Tests like transaminases, complete blood counts, and hemoglobin A1c are excluded because they track toxicities of other drug classes.
This prevents ordering unnecessary diagnostic tests and avoids confusing lithium's profile with that of valproate, carbamazepine, or atypical antipsychotics.

Anahtar Kavram

Patients on maintenance lithium therapy require periodic monitoring of renal function (serum creatinine/BUN), thyroid function (thyroid-stimulating hormone), and parathyroid function (serum calcium) due to the drug's long-term organ toxicities.
Soru 1111Soru →

An 85-year-old man is evaluated for discharge planning. He was admitted 8 days ago for urosepsis complicated by a non-ST-segment elevation myocardial infarction (NSTEMI). He spent 4 days in the intensive care unit requiring vasopressor support and was subsequently transferred to the medical ward. He is now hemodynamically stable, afebrile, and his white blood cell count has normalized to 7,500/mm³. He is currently receiving a 14-day course of intravenous ceftriaxone via a peripherally inserted central catheter (PICC) and has 6 days of therapy remaining.

Prior to admission, the patient lived at home with his 82-year-old wife and ambulated independently with a cane. His wife has severe osteoarthritis and uses a wheeled walker for mobility.

Currently, the patient is alert and oriented to person, place, and time. Physical examination reveals generalized muscle weakness. Physical and occupational therapy evaluations indicate that he requires maximal assistance for bed-to-chair transfers and cannot ambulate safely. He fatigues rapidly during therapy sessions, tolerating a maximum of 30 minutes of active physical rehabilitation per day due to cardiopulmonary deconditioning.

Which of the following is the most appropriate disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Discharge to a skilled nursing facility

Cevap

Discharge to a skilled nursing facility
The correct disposition is discharge to a skilled nursing facility (SNF). This patient requires a structured environment for three specific reasons: completion of intravenous antibiotics, assistance with severe functional deficits (maximal assist for transfers), and physical therapy to recover from post-ICU deconditioning. Because his wife has severe osteoarthritis and uses a walker, she cannot safely assist him with transfers at home, making a home discharge unsafe even with intermittent home health visits. Furthermore, his cardiopulmonary deconditioning limits his therapy tolerance to only 30 minutes per day. This explicitly disqualifies him from an inpatient rehabilitation facility (IRF), which strictly requires patients to be capable of participating in at least 3 hours of intensive therapy daily. An SNF bridges this gap by providing daily skilled nursing care (IV medications), subacute physical therapy at a tolerable pace, and the 24-hour custodial support necessary for his safety.

Adım Adım Çözüm

1
Assess the patient's ongoing medical and functional needs.
The patient requires 6 additional days of intravenous antibiotics, physical therapy for severe post-ICU deconditioning, and maximal assistance for transfers.
Identifying ongoing requirements establishes the baseline level of care required after hospital discharge.
2
Evaluate the patient's functional capacity and tolerance for rehabilitation.
The patient can only tolerate 30 minutes of therapy per day due to cardiopulmonary fatigue.
Rehabilitation tolerance is the primary differentiator between acute inpatient rehabilitation (requires 3 hours/day) and subacute rehabilitation (accommodates lower endurance).
3
Assess the social support system and home environment safety.
The patient's wife uses a walker and is physically unable to assist with maximal-assist transfers.
A safe discharge home requires either patient independence or a capable caregiver; without either, a facility-based disposition is mandatory to prevent falls and caregiver injury.
4
Synthesize findings to select the appropriate facility.
A skilled nursing facility (SNF) is selected.
An SNF safely provides the necessary IV antibiotic administration, subacute rehabilitation tailored to his low endurance, and 24-hour assistance with activities of daily living.

Anahtar Kavram

Disposition to post-acute care settings requires matching the patient's medical needs, rehabilitation tolerance (e.g., IRF vs. SNF criteria), and available home support structure to ensure safe transitions of care.
Soru 1112Soru →

A physician evaluates a 62-year-old female patient who presents for a scheduled health maintenance visit. Her past medical history is notable for hypertension, osteoarthritis, and a total abdominal hysterectomy with bilateral salpingo-oophorectomy performed for symptomatic uterine fibroids at age 45. She has consumed half a pack of cigarettes per day continuously since she was 22 years old. She currently takes amlodipine and acetaminophen. She reports feeling well without any new symptoms. Physical examination shows a blood pressure of 126/78 mm Hg and a body mass index of 24 kg/m². A recently calculated 10-year major osteoporotic fracture risk using the FRAX assessment tool is 4.2%.

Review of her preventive care timeline demonstrates:
- A colonoscopy at age 54 with no abnormal findings.
- A screening mammogram completed 6 months ago that was interpreted as normal.
- A negative Hepatitis C virus antibody assay at age 58.
- Documentation of the 20-valent pneumococcal conjugate vaccine (PCV20) administered at age 60, alongside an up-to-date annual influenza vaccination.

Which of the following interventions is the most appropriate next step in this patient's preventive care?

Cevabı ve açıklamayı göster

Cevap: Annual low-dose computed tomography of the chest

Cevap

Annual low-dose computed tomography of the chest
The correct answer is annual low-dose computed tomography of the chest. The United States Preventive Services Task Force (USPSTF) recommends annual lung cancer screening with low-dose computed tomography (LDCT) for adults aged 50 to 80 years who have at least a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. This patient has smoked 0.5 packs per day for 40 years (from age 22 to 62), which equates to exactly a 20 pack-year history. Because she meets the age criteria, meets the updated pack-year threshold, and is a current smoker, LDCT is strongly indicated to reduce lung cancer-specific mortality.

Adım Adım Çözüm

1
Calculate the patient's smoking pack-year history.
The patient has smoked 0.5 packs per day for 40 years (from age 22 to 62). 0.5 x 40 = 20 pack-years.
Accurate pack-year calculation is essential to determine eligibility for lung cancer screening.
2
Evaluate the patient against USPSTF lung cancer screening criteria.
She is between 50 and 80 years old, has exactly a 20 pack-year history, and currently smokes. Therefore, she meets all indications for annual screening.
To identify if a high-value, mortality-reducing preventive intervention is currently due.
3
Assess the necessity of other preventive screenings based on her specific history.
Colonoscopy is deferred until age 64 (10 years after a normal result). Cervical screening is contraindicated due to prior total hysterectomy for benign disease. DEXA is deferred because she is under 65 and her FRAX score (4.2%) is below the 8.4% threshold. AAA screening is not routinely indicated in women.
To systematically eliminate distractors that represent mistimed or inappropriate care.

Anahtar Kavram

The USPSTF recommends annual lung cancer screening with low-dose computed tomography (LDCT) for adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or have quit within the past 15 years.

Alternatif Yöntem

Calculate pack-years by multiplying the total number of cigarettes smoked per day by the number of years smoked, then dividing by 20 (the standard number of cigarettes in a pack). (10 cigarettes/day * 40 years) / 20 = 20 pack-years.
Tahmini Süre:1m 30s
Soru 1113Soru →

A 62-year-old woman is admitted to the hospital with a 2-day history of acute right leg swelling and right-sided pleuritic chest pain. She has a history of type 2 diabetes mellitus, hypertension, and chronic kidney disease stage 4. Her home medications include amlodipine, insulin glargine, and atorvastatin. On presentation, her blood pressure is 138/85 mmHg, pulse is 105/min, and oxygen saturation is 94% on room air. Laboratory studies show a serum creatinine of 3.2 mg/dL3.2 \text{ mg/dL} (estimated glomerular filtration rate: 18 mL/min/1.73 m218 \text{ mL/min/1.73 m}^2). A computed tomography (CT) pulmonary angiogram confirms a right lower lobe segmental pulmonary embolism. A comprehensive lower extremity venous ultrasound demonstrates a proximal deep vein thrombosis in the right popliteal vein. Continuous intravenous unfractionated heparin is initiated.

Which of the following are necessary components of this patient's ongoing treatment and monitoring plan? (Select two)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Serial measurement of activated partial thromboplastin time (aPTT) every 6 hours until the therapeutic target is achieved; Monitoring of the platelet count every 2 to 3 days to evaluate for drug-induced complications

Cevap

The correct monitoring parameters are the serial measurement of activated partial thromboplastin time (aPTT) to ensure therapeutic anticoagulation and regular monitoring of the platelet count to assess for heparin-induced thrombocytopenia.
The use of intravenous unfractionated heparin requires precise monitoring due to its unpredictable pharmacokinetic profile. Efficacy is monitored by checking the activated partial thromboplastin time (aPTT) every 6 hours after initiation or dose adjustments until two consecutive values are within the target therapeutic range. Furthermore, because unfractionated heparin carries a high risk of heparin-induced thrombocytopenia (HIT), patients must have their platelet counts monitored regularly (e.g., every 2 to 3 days from day 4 to 14 of therapy) to identify a precipitous drop that would necessitate immediate cessation of heparin and transition to a non-heparin anticoagulant.

Adım Adım Çözüm

1
Evaluate the patient's clinical presentation, comorbidities, and current therapy.
The patient has an acute pulmonary embolism and deep vein thrombosis in the setting of severe chronic kidney disease (eGFR 18 mL/min/1.73 m218 \text{ mL/min/1.73 m}^2) and is appropriately started on intravenous unfractionated heparin (UFH).
Severe renal impairment restricts the use of low-molecular-weight heparins (like enoxaparin) and most direct oral anticoagulants due to the risk of bioaccumulation and fatal bleeding. UFH is primarily cleared by the reticuloendothelial system and is the safest initial option.
2
Identify the appropriate efficacy monitoring for intravenous unfractionated heparin.
The intrinsic and common coagulation pathways must be monitored using the activated partial thromboplastin time (aPTT).
UFH binds to antithrombin, enhancing its inactivation of thrombin (Factor IIa) and Factor Xa. The aPTT is measured every 6 hours until therapeutic (typically 1.5 to 2.5 times the control value), then daily.
3
Identify the required safety monitoring for unfractionated heparin therapy.
The patient requires regular monitoring of her platelet count.
UFH carries a significant risk of inducing heparin-induced thrombocytopenia (HIT), an immune-mediated prothrombotic state caused by antibodies against heparin-platelet factor 4 complexes.

Anahtar Kavram

Patients with acute venous thromboembolism and severe renal impairment should be treated with intravenous unfractionated heparin, which requires frequent aPTT monitoring to ensure therapeutic dosing and serial platelet count monitoring to detect heparin-induced thrombocytopenia.
Soru 1114Soru →

An oncologist evaluates a 5252-year-old woman during a routine follow-up visit. The patient has HER2-amplified, estrogen receptor-negative early-stage breast cancer. Three months ago, she completed adjuvant therapy with doxorubicin and cyclophosphamide and was subsequently started on maintenance therapy with trastuzumab.

The patient reports feeling well with no shortness of breath, orthopnea, or lower extremity edema. She walks 33 kilometers daily without difficulty. Vital signs are within normal limits. Physical examination reveals clear lungs bilaterally, no jugular venous distention, and no peripheral edema.

A summary of her echocardiogram reports is provided below:

ParameterBaseline (Pre-Trastuzumab)Current (Today)
Left Ventricular Ejection Fraction (LVEF)62%62\%46%46\%
Regional Wall MotionNormalDiffuse global hypokinesis
Right Ventricular FunctionNormalNormal
Valvular AssessmentTrace mitral regurgitationTrace mitral regurgitation

Which of the following is the most appropriate next step in managing this patient's therapy?

Cevabı ve açıklamayı göster

Cevap: Hold trastuzumab and repeat echocardiography in 4 weeks

Cevap

The most appropriate next step is to hold trastuzumab and repeat echocardiography in 4 weeks.
The correct answer involves holding trastuzumab and repeating the echocardiogram in 4 weeks. Trastuzumab is associated with Type II cardiotoxicity, which usually presents as an asymptomatic decline in Left Ventricular Ejection Fraction (LVEF). Standard oncology guidelines mandate holding trastuzumab if the LVEF drops by ≥16%\geq 16\% from baseline, or if the LVEF falls below the institutional limits of normal (usually <50%< 50\%) with a ≥10%\geq 10\% absolute drop. This patient's LVEF dropped from 62%62\% to 46%46\%, which satisfies both criteria. Because this toxicity is generally reversible and non-dose-dependent, the drug is held temporarily rather than discontinued permanently, and cardiac function is reassessed in 4 weeks to determine if therapy can be safely resumed.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and echocardiogram results.
The patient is completely asymptomatic, but her LVEF has decreased from 62%62\% to 46%46\% (an absolute drop of 16%16\%) over three months of trastuzumab therapy.
Identifying the precise magnitude of the LVEF decline is required to accurately apply oncologic monitoring guidelines.
2
Apply the clinical guidelines for trastuzumab-induced cardiotoxicity.
Because the absolute LVEF decrease is ≥16%\geq 16\% (and the total LVEF is below the normal limit of 50%50\%), the drug must be temporarily held to prevent progression to symptomatic heart failure.
Continuing the medication when standard cessation thresholds are met is contraindicated and risks severe patient harm.
3
Determine the appropriate follow-up monitoring interval.
A repeat echocardiogram should be scheduled in 4 weeks to assess for myocardial recovery.
Because Type II cardiotoxicity is often transient and reversible, reassessment in 4 weeks allows time for recovery while preventing premature permanent discontinuation of a highly effective cancer therapy.

Anahtar Kavram

Management of Trastuzumab-Induced Cardiotoxicity
Soru 1115Soru →

A 45-year-old woman returns to the outpatient clinic to review the results of a recent breast biopsy. The pathology report confirms a diagnosis of invasive ductal carcinoma. The physician prepares to deliver this bad news to the patient. Arrange the following physician statements in the most appropriate chronological order according to the established framework for delivering bad news (the SPIKES protocol).

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct order follows the SPIKES protocol: Setting up the interview, assessing the patient's Perception, obtaining an Invitation, giving Knowledge, addressing Emotions, and establishing Strategy and Summary.
The correct order follows the SPIKES protocol for delivering bad news. First, the Setting (S) must be optimized for privacy. Next, the physician assesses the patient's Perception (P) of the situation. Then, an Invitation (I) is obtained to determine how much detail the patient desires. Only after these preparatory steps is Knowledge (K) imparted, giving the diagnosis clearly. Following the news, the physician must address Emotions (E) empathetically. Finally, Strategy and Summary (S) are discussed to formulate a plan moving forward.

Adım Adım Çözüm

1
Identify the clinical objective from the vignette.
The physician must deliver bad news regarding a new cancer diagnosis.
Establishing the clinical goal dictates the most appropriate communication framework to use.
2
Select the evidence-based communication framework for this scenario.
The SPIKES protocol is the standard, six-step framework for delivering bad news.
SPIKES ensures bad news is delivered empathetically while maximizing comprehension and respecting patient autonomy.
3
Map the physician's statements to the SPIKES sequence chronologically.
Setting -> Perception -> Invitation -> Knowledge -> Emotions -> Strategy.
Following this exact sequence minimizes psychological trauma, evaluates readiness, and provides clear next steps only after emotions are validated.

Anahtar Kavram

The SPIKES protocol for delivering bad news
Tahmini Süre:1m 0s
Soru 1116Soru →

A 6464-year-old man presents to the clinic for a follow-up visit. Over the past four weeks, he has experienced progressive fatigue, an unintentional weight loss of 44 kg (8.88.8 lb), and intermittent palpitations. He has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of 30%30\% and recurrent sustained ventricular tachycardia. His medications include lisinopril, carvedilol, spironolactone, and amiodarone. He has been taking amiodarone for the past 22 years. Vital signs show a blood pressure of 118/76118/76 mmHg and an irregularly irregular pulse of 112112/min. Physical examination is notable for a fine resting tremor and warm, diaphoretic skin. The thyroid gland is not enlarged, and there is no tenderness to palpation.

Laboratory studies reveal the following:

TestResultReference Range
Thyroid-stimulating hormone (TSH)<0.01<0.01 μ\muU/mL0.40.4-4.04.0 μ\muU/mL
Free T43.53.5 ng/dL0.70.7-1.91.9 ng/dL
Free T36.26.2 pg/mL2.02.0-4.44.4 pg/mL

A color flow Doppler ultrasonography of the thyroid gland demonstrates a normal-sized gland with markedly decreased vascular flow.

Which of the following is the most appropriate next step in the pharmacologic management of this patient's thyroid dysfunction?

Cevabı ve açıklamayı göster

Cevap: Initiate oral prednisone

Cevap

The correct answer is to initiate oral prednisone.
The correct answer is to initiate oral prednisone. This patient has developed amiodarone-induced thyrotoxicosis (AIT) during ongoing pharmacologic monitoring. Amiodarone is highly iodine-rich and can cause two distinct types of thyrotoxicosis. AIT type 1 typically occurs in patients with underlying thyroid disease (e.g., multinodular goiter) and is driven by excessive hormone synthesis fueled by the massive iodine load; color flow Doppler ultrasonography demonstrates increased vascularity. In contrast, AIT type 2 occurs in patients with a previously normal thyroid and represents a destructive thyroiditis caused by amiodarone's direct toxic effects on follicular cells. This destruction leads to the release of preformed thyroid hormone, and ultrasound classically demonstrates decreased vascularity. Because AIT type 2 is an inflammatory process rather than a state of true hyperthyroidism, the most appropriate pharmacologic treatment modification is the initiation of glucocorticoids, such as oral prednisone, to reduce inflammation and stabilize the follicular cells.

Adım Adım Çözüm

1
Interpret the clinical presentation and laboratory findings to establish the primary complication of the patient's pharmacotherapy.
The patient has a suppressed TSH with elevated free T4 and T3, alongside symptoms of palpitations, weight loss, and tremor, confirming a diagnosis of thyrotoxicosis secondary to amiodarone.
Accurate interpretation of thyroid function tests is essential before adapting a high-risk medication regimen.
2
Analyze the color flow Doppler ultrasonography results to distinguish the specific subtype of toxicity.
The ultrasound demonstrates markedly decreased vascular flow, which differentiates amiodarone-induced destructive thyroiditis (type 2) from hyperthyroidism caused by increased hormone synthesis (type 1).
Amiodarone can cause two distinct types of thyrotoxicosis that mandate entirely different treatment modifications.
3
Select the appropriate pharmacologic management based on the toxicity subtype.
The patient has amiodarone-induced thyrotoxicosis (AIT) type 2. The standard of care is to initiate a glucocorticoid, such as oral prednisone, to suppress the inflammatory destruction of the thyroid follicles.
Unlike AIT type 1, which requires anti-thyroid drugs to block synthesis, AIT type 2 is an inflammatory condition that responds best to glucocorticoids.

Anahtar Kavram

Amiodarone-induced thyrotoxicosis type 2 is a destructive thyroiditis characterized by decreased vascularity on ultrasound and requires the initiation of glucocorticoids; it differs from type 1, which involves increased hormone synthesis and is treated with thionamides.
Soru 1117Soru →

During an outpatient endocrine evaluation, a physician evaluates a patient suffering from new-onset, treatment-resistant hypertension, marked proximal myopathy, and progressive truncal adiposity. The patient exhibits classic cutaneous findings, including facial plethora and broad, violaceous abdominal striae. Recent laboratory work definitively established a diagnosis of endogenous hypercortisolism via two distinct, abnormal screening tests: a markedly elevated late-night salivary cortisol and an unsuppressed morning cortisol following a 1-mg overnight dexamethasone suppression test. To elucidate the underlying etiology of this patient's hypercortisolism, which of the following investigations is the most appropriate next step in the diagnostic sequence?

Cevabı ve açıklamayı göster

Cevap: Measurement of plasma adrenocorticotropic hormone

Cevap

Measurement of plasma adrenocorticotropic hormone
Once endogenous hypercortisolism (Cushing syndrome) is confirmed with at least two abnormal first-line tests (such as late-night salivary cortisol, 24-hour urine free cortisol, or 1-mg overnight dexamethasone suppression test), the strict next step in the diagnostic sequence is to measure a plasma adrenocorticotropic hormone (ACTH) level. This crucial biochemical step differentiates ACTH-dependent causes (e.g., pituitary adenoma, ectopic ACTH production) from ACTH-independent causes (e.g., adrenal adenoma or carcinoma). Performing anatomical imaging or further dynamic endocrine testing before this basic biochemical categorization can lead to unnecessary, misdirected, or invasive procedures due to the high prevalence of incidentalomas.

Adım Adım Çözüm

1
Evaluate the current diagnostic status of the patient based on the clinical vignette.
The patient has established endogenous Cushing syndrome based on two concordant, abnormal first-line screening tests (elevated salivary cortisol and abnormal 1-mg overnight dexamethasone suppression test).
Before pursuing etiology, the presence of hypercortisolism must be biochemically confirmed to avoid chasing false positives.
2
Determine the required diagnostic sequence for identifying the etiology of confirmed hypercortisolism.
The algorithm dictates that biochemical localization must precede anatomical localization.
Incidentalomas (both pituitary and adrenal) are common in the general population. Imaging without biochemical guidance often leads to false attribution of the disease source.
3
Select the specific biochemical test that categorizes the hypercortisolism.
Plasma adrenocorticotropic hormone (ACTH) measurement is selected.
An ACTH level robustly separates ACTH-dependent causes (normal or elevated ACTH) from ACTH-independent causes (suppressed ACTH), dictating whether pituitary or adrenal imaging is subsequently appropriate.

Anahtar Kavram

Diagnostic sequencing for Cushing syndrome etiology
Tahmini Süre:1m 15s
Soru 1118Soru →

A female patient, aged 64, is evaluated in the ambulatory clinic for ongoing exertional dyspnea. She was diagnosed with heart failure with reduced ejection fraction two years ago following an anterior myocardial infarction. Current symptoms include shortness of breath when walking up a single flight of stairs, consistent with New York Heart Association class II symptoms. Her medical history includes type 2 diabetes mellitus and hypertension.

Current medications are lisinopril, metoprolol succinate, empagliflozin, and torsemide as needed.

Vital signs show a blood pressure of 118/76118/76 mm Hg and a heart rate of 6868/min. Physical examination reveals a normal jugular venous pressure, clear lungs, and trace bilateral pedal edema.

Recent laboratory studies:
Sodium: 138138 mEq/L
Potassium: 4.54.5 mEq/L
Creatinine: 1.11.1 mg/dL (baseline 1.01.0 mg/dL)

An echocardiogram from one month ago shows a left ventricular ejection fraction of 32%32\%.

The physician plans to transition the patient from her current angiotensin-converting enzyme inhibitor to sacubitril-valsartan to further reduce the risk of cardiovascular mortality and heart failure hospitalization.

Which of the following is the most appropriate step in implementing this pharmacologic intervention?

Cevabı ve açıklamayı göster

Cevap: Discontinue lisinopril and initiate sacubitril-valsartan after a 36-hour washout period

Cevap

Discontinue lisinopril and initiate sacubitril-valsartan after a 36-hour washout period.
The correct approach when switching a patient from an angiotensin-converting enzyme (ACE) inhibitor (like lisinopril) to an angiotensin receptor-neprilysin inhibitor (ARNI) (like sacubitril-valsartan) is to enforce a strict 36-hour washout period. Both ACE and neprilysin are enzymes responsible for the degradation of bradykinin. Simultaneous inhibition of both pathways significantly increases bradykinin levels, which can precipitate life-threatening angioedema. The 36-hour window ensures adequate clearance of the ACE inhibitor before neprilysin inhibition begins. Note that this washout period is not required when transitioning from an angiotensin receptor blocker (ARB) to an ARNI.

Adım Adım Çözüm

1
Identify the indication for the pharmacologic change
The patient has symptomatic HFrEF (NYHA class II, LVEF 32%) on optimal medical therapy including an ACE inhibitor, beta-blocker, and SGLT2 inhibitor. Upgrading the ACE inhibitor to an ARNI (sacubitril-valsartan) is guideline-directed.
ARNIs provide superior reduction in morbidity and mortality compared to ACE inhibitors in patients with chronic symptomatic HFrEF.
2
Determine the specific pharmacokinetic and pharmacodynamic requirements for initiating an ARNI
Sacubitril-valsartan cannot be administered concurrently with an ACE inhibitor due to a synergistic accumulation of bradykinin.
ACE breaks down bradykinin, and neprilysin also breaks down bradykinin. Inhibiting both simultaneously severely increases the risk of angioedema.
3
Establish the correct protocol for transitioning medications
A minimum 36-hour washout period is required after the last dose of the ACE inhibitor before the first dose of the ARNI can be administered.
This specific timeframe allows for adequate clearance of the ACE inhibitor, mitigating the interaction and safely facilitating the transition.

Anahtar Kavram

When transitioning a patient with heart failure from an angiotensin-converting enzyme (ACE) inhibitor to an angiotensin receptor-neprilysin inhibitor (ARNI), a strict 36-hour washout period is required to minimize the risk of angioedema.
Soru 1119Soru →

A 42-year-old man presents to the clinic for a routine evaluation. He reports a 2-year history of excessive sweating, fatigue, and loud snoring that frequently wakes his spouse. He mentions that his wedding ring no longer fits and his shoe size has increased from size 10 to 12 over the past few years. He has a history of hypertension and takes amlodipine. Vital signs show a blood pressure of 152/94 mm Hg, pulse of 78/min, and BMI of 31 kg/m². Physical examination reveals coarse facial features, a prominent jaw, and a widened space between his lower incisors. His hands are enlarged and doughy. There is no visual field deficit on confrontation testing. Which of the following is the most appropriate next step in the diagnostic workup of this patient's condition?

Cevabı ve açıklamayı göster

Cevap: Measurement of serum insulin-like growth factor 1 level

Cevap

The most appropriate next step is the measurement of serum insulin-like growth factor 1 (IGF-1) level.
The correct answer is the measurement of serum insulin-like growth factor 1 (IGF-1) level. This patient's presentation of acral enlargement (increasing shoe and ring size), coarse facial features, hyperhidrosis, and secondary complications (hypertension, loud snoring suggesting obstructive sleep apnea) is highly suspicious for acromegaly, a syndrome caused by excess growth hormone (GH) secretion, typically from a pituitary adenoma. Because GH is secreted in a highly pulsatile fashion and has a short half-life, random serum GH levels are not reliable for screening. Instead, the initial test of choice is the measurement of serum IGF-1. IGF-1 is produced by the liver in response to GH, has a longer half-life, and provides a stable, integrated measure of GH secretion over time.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient exhibits classic signs of acromegaly, including progressive enlargement of the extremities (increasing shoe size, tight ring), coarse facial features, macrognathia, widened incisor spaces, hyperhidrosis, and secondary complications like hypertension and suspected obstructive sleep apnea.
Recognizing the syndrome is necessary to initiate the specific diagnostic algorithm.
2
Determine the appropriate initial diagnostic screening test for suspected acromegaly.
Measurement of serum IGF-1 is the initial test of choice.
Growth hormone (GH) is secreted in a highly pulsatile manner by the pituitary gland, making random GH levels uninterpretable. IGF-1 is secreted by the liver in response to GH and has a long half-life, providing a stable reflection of integrated GH secretion.
3
Sequence the subsequent diagnostic steps if the initial screen is abnormal.
If IGF-1 is elevated, the diagnosis is confirmed with an oral glucose tolerance test (OGTT) with GH measurement. Only after biochemical confirmation should an MRI of the brain (pituitary) be ordered.
Proper test sequencing prevents the pursuit of incidentalomas on imaging and ensures cost-effective, evidence-based care.

Anahtar Kavram

The initial diagnostic step for suspected acromegaly is measurement of serum insulin-like growth factor 1 (IGF-1), followed by an oral glucose tolerance test (OGTT) for confirmation, and finally an MRI of the brain to localize the pituitary adenoma.
Tahmini Süre:1m 0s
Soru 1120Soru →

While awaiting a routine appointment in the outpatient pulmonary clinic, a 6262-year-old man suddenly begins coughing up large volumes of bright red blood. Within minutes, he expectorates more than 400 mL400\text{ mL} of blood into a basin. The patient becomes highly agitated, profoundly diaphoretic, and visibly struggles to breathe. His medical history is significant for pulmonary tuberculosis that was treated 1515 years ago. Clinic staff immediately transfer him to the adjacent emergency department resuscitation bay. Vital signs show a heart rate of 128/min128/\text{min}, blood pressure of 115/75 mmHg115/75\text{ mmHg}, and a respiratory rate of 34/min34/\text{min}. Pulse oximetry reveals an oxygen saturation of 83%83\% on room air. Chest auscultation demonstrates coarse gurgling and diminished breath sounds predominantly over the right lung fields.

Which of the following is the most appropriate immediate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Perform endotracheal intubation

Cevap

Perform endotracheal intubation
The patient is experiencing massive hemoptysis (defined as expectorating >100-600 mL of blood in 24 hours, or any amount causing hemodynamic or respiratory instability). He is presenting with acute respiratory failure, evidenced by profound hypoxemia, severe tachypnea, and respiratory distress. The most common immediate cause of death in massive hemoptysis is asphyxiation from blood flooding the airways, not exsanguination. Therefore, securing the airway via endotracheal intubation is the single most urgent initial stabilization step. Once the airway is protected, the patient should ideally be positioned with the bleeding lung dependent (in this case, right side down, based on auscultation) to prevent blood from spilling into the unaffected lung, followed by definitive diagnosis and treatment (e.g., bronchoscopy or bronchial artery embolization).

Adım Adım Çözüm

1
Recognize the clinical presentation of massive hemoptysis with impending respiratory failure.
The patient has expectorated >400 mL of blood rapidly and is showing severe hypoxemia (SpO2 83%), tachypnea, and respiratory distress.
Identifying the severity of the bleed and its immediate impact on respiratory mechanics dictates the triage priority.
2
Identify the primary pathophysiological threat to the patient's life in this specific scenario.
The immediate risk is asphyxiation (drowning in blood) due to airway flooding, rather than exsanguination.
The anatomic dead space of the major airways is roughly 150 mL; rapidly coughing up larger volumes easily overwhelms the airway.
3
Select the intervention that addresses the most immediate life-threatening problem.
Endotracheal intubation is selected as the first step.
Securing the airway guarantees ventilation, provides oxygenation, allows for suctioning, and facilitates subsequent procedures like bronchoscopy.

Anahtar Kavram

In the initial stabilization of massive hemoptysis, the primary life-threatening risk is asphyxiation, making airway protection via endotracheal intubation the absolute first priority before diagnostic imaging or source control.
Tahmini Süre:1m 30s
ÖncekiSayfa 56 / 104Sonraki
Patient Management Alıştırma Soruları — USMLE Step 3 — Sayfa 56 | Examkin